C3.ai delivered $145.4 million in total revenue during the first half of its fiscal year 2026 (ended Oct. 31), which was down ...

C3.ai, Inc. (NYSE: AI) is one of the best agentic AI stocks to buy now. On December 9, 2025, the company announced that the U ...

C3 AI has received FedRAMP (Federal Risk and Authorization Management Program) authorization, which opens the door for ...

Yes, waiting could mean missing out on the stock's lowest price. But waiting also protects you from losses. Remember, C3.ai ...

Now that C3.ai has won a major government approval, will it finally be enough to coax hesitant investors toward its beaten-down shares?

C3.ai (NYSE:AI) was once hailed as a pioneer in enterprise AI software, but today grapples with a cascade of challenges that ...

C3 Metals Inc. (TSXV: CCCM) (OTCQB: CUAUF) (“C3 Metals” or the “Company”) is pleased to announce that the first hole ever ...

Shares of C3.ai have pulled back substantially, but there are signs of a potential turnaround. C3.ai's guidance for the current year suggests a significant decline in the top line. The business is ...

C3.ai stock drops after weak Q2 and FY26 outlook, but rising federal bookings signal recovery. Read here for an investment ...

The Universidad Carlos III de Madrid (UC3M) inaugurated today its Scientific Computing Center (C3), a new state-of-the-art ...

The department plans to use the company's agentic artificial intelligence to integrate disease-specific NIH data with ...

Affecting roughly 5,000 people in the U.S., C3 glomerulopathy and immune-complex MPGN are two rare glomerulopathies ...